APUS
#4763
Apimeds Pharmaceuticals US, Inc. Common Stock
4.5 5 USD
-0.11%
Market Price
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
Годовой диапазон
Дневное изменение
-11.31%
Месячное изменение
+115.64%
6-месячное изменение
+127.50%
Годовое изменение
+247.33%
Предыдущее закрытие
5.1 3
Open
4.8 0
Low
4.2 6
High
4.8 0
Financials
2026
Current report, 29 Sep 2026
Apimeds Pharmaceuticals US, Inc. current report, 29 September 2026
8-K
Current report, 24 Sep 2026
Apimeds Pharmaceuticals US, Inc. current report, 24 September 2026
8-K
Current report, 10 Sep 2026
Apimeds Pharmaceuticals US, Inc. current report, 10 September 2026
8-K
Current report, 19 Aug 2026
Apimeds Pharmaceuticals US, Inc. current report, 19 August 2026
8-K
Current report, Q3 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q3 FY2026
8-K
Current report, 24 Jul 2026
Apimeds Pharmaceuticals US, Inc. current report, 24 July 2026
8-K
Current report, Q3 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Apimeds Pharmaceuticals US, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q2 FY2026
8-K